Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ICU Medical Inc Lowers FY 2013 Revenue Guidance; Lowers High End Of Prior FY 2013 EPS Guidance; Announces Management Transition


Monday, 21 Oct 2013 04:05pm EDT 

ICU Medical, Inc announced that for fiscal 2013, it expects to generate revenue in the range of $319 million to $321 million, compared to the previous guidance of $320 million to $325 million. The Company expects its diluted earnings to be in the range of $2.50 to $2.55 per diluted share, compared to the previous guidance of $2.50 to $2.60 per diluted share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $322 million and EPS of $2.54 for fiscal 2013. The Company also announced that due to health reasons Dr. George Lopez, (Doc) will step down as President and Chief Executive Officer. He will continue in his role as Chairman of the Board and will remain an employee in the Research and Development Department. The Company also announced that its Board of Directors has appointed Steven Riggs, current Vice President of Operations, as Acting Chief Executive Officer, effective immediately. 

Company Quote

83.77
-0.18 -0.21%
19 Dec 2014